Note dell’episodio
You've probably seen the headlines about Ozempic and other GLP-1 drugs and Alzheimer's disease. One week it sounds like a breakthrough. The next, not so much.
A large study found a much lower rate of Alzheimer's diagnoses in people taking these medications. Then a major clinical trial published this year found something very different.
Neither one is wrong. And understanding why matters, especially if you're the one trying to make sense of it for your family.
In this video I walk you through what the research on Ozempic and other GLP-1 drugs actually found, the meaningful difference…
Sito web: 9012c50b-5677-43dc-8e00-e8e196a0f910.libsyn.com

